Gene repair involving in vivo excision of targeting DNA

Details Gene repair involving in vivo excision of targeting DNA Gene repair involving in vivo excision of targeting DNA

2007-10-23

2007-10-23

Woitach, Joseph (Department: 1633)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S093100, C435S320100, C536S023100

Reexamination Certificate

active

10336069

ABSTRACT:
Methods of modifying, repairing, attenuating and inactivating a gene or other chromosomal DNA in a cell are disclosed. Also disclosed are methods of treating or prophylaxis of a genetic disease in an individual in need thereof.

REFERENCES:
patent: 5436150 (1995-07-01), Chandrasegaran
patent: 5674499 (1997-10-01), Willemse et al.
patent: 5792632 (1998-08-01), Dujon et al.
patent: 5830729 (1998-11-01), Jaisser et al.
patent: 5962327 (1999-10-01), Dujon et al.
patent: 6238924 (2001-05-01), Dujon et al.
patent: 7098031 (2006-08-01), Choulika et al.
patent: 2002/0107214 (2002-08-01), Choulika et al.
patent: 2004/0019002 (2004-01-01), Choulika et al.
patent: WO96/14408 (1996-05-01), None
patent: WO 00/46386 (2000-08-01), None
Deonarain (1998) Exp. Opin. Ther. Pat., 8(1): 53-69.
Gorecki (2001) Exp. Opin. Emerging Drugs, 6(2): 187-98.
Eck, et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, New York, NY., pp. 77-101.
Plessis, et al. (1992) Genetics, 130: 451-460.
Rouet, et al. (1994) Proc. Natl. Acad. Sci., USA., 91: 6064-68.
Cohen-Tannoudji, et al. (1998) Mol. Cell. Biol., 18(3): 1444-48.
Gunzberg, et al. (1995) Mol. Med. Today, 1(9): 410-17 (Abstract Only).
Belfort, M. and Roberts, R.J., “Homing endonucleases: keeping the house in order,”Nucleic Acids Res. 25(17):3379-3388 (1997).
Grindl, W., et al., “The protein splicing domain of the homing endonuclease PI-SceI is responsible for specific DNA binding,”Nucleic Acids Res. 26(8): 1857-1862 (1998).
Pósfai, G., et al., “Markerless gene replacement inEscherichia colistimulated by a double-strand break in the chromosome,”Nucleic Acids Res. 27(22): 4409-4415 (1999).
Choulika, A. et al., “The Yeast I-SCE I Meganuclease Induces Site-Direccted Chromosomal Recombination in Mammalian Cells,”C.R. Acad. Sci. Paris, Life Sciences, Genetics, 317:1013-1019 (1994).
Cohen-Tannoudji, M. et al., “I-SceI-Induced Gene Replacement at a Natural Locus in Embryonic Stem Cells,”Molecular and Cellular Biology, 18(3):1444-1448 (1998).
Choulika, A. et al., “Induction of Homologous Recombination in Mammalian Chromosomes by Using the I-SceI System ofSaccharomyces cerevisiae,” Molecular and Cellular Biology, 15(4):1968-1973 (1995).
Smith, J. et al., “A Detailed Study of the Substrate Specificity of a Chimeric Restriction Enzyme,”Nucleic Acids Res., 27(2):674-681 (1999).
Nahon, E. and Raveh, D., “Targeting a Truncated Ho-Endonuclease of Yeast to Novel DNA Sites with Foreign Zinc Fingers,”Nucleic Acids Res., 26(5):1233-1239 (1998).
Kim, Y.G. et al., “Hybrid Restriction Enzymes: Zinc Finger Fusions to Fok I Cleavage Domain,”Proc. Natl. Acad. Sci. USA, 93(3):1156-1160 (1996).
Anderson, W.F., “Human Gene Therapy,”Nature, 392:25-30 (1998).
Nishikawa, M. et al., “Nonviral Vectors in the Millennium: Delivery Barriers in Gene Transfer,”Human Gene Therapy, 12:861-870 (2001).
Rozenberg, Y. et al., “Alternative Gene Delivery,”S.T.P. Pharma Sciences, 11:21-30 (2001).
Balicki, D. et al., “Gene Therapy of Human Disease,”Medicine, 81:69-86 (2002).
Orkin, S. H. and Motulsky, A.G., “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”, National Institutes of Health, 1-41 (Dec. 7, 1995).
Verma, I. M. et al., “Gene Therapy- Promises, Problems and Prospects”,Nature, 389:239-242 (1997).
Ross, G. et al., “Gene Therapy in the United States: A Five-Year Status Report”,Human Gene Therapy, 7:1781-1790 (1996).
Marshall, E., “Gene Therapy's Growing Pains”,Science, 269:1050-1055 (1995).
“There are Common Motifs in Many Sequence-specific DNA-binding Proteins”, InMolecular Biology of the Cell, 2nded. Alberts, B. et al.(eds). (Garland Publishing, New York), Chap. 9, p. 490 (1989).
Promega “Revolutions in Science”, 1993/94 Catalog, p. 20.

Affiliated with

Also associated with

Rating

Gene repair involving in vivo excision of targeting DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene repair involving in vivo excision of targeting DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene repair involving in vivo excision of targeting DNA will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3847676